Important NIA Monday Afternoon Update

Be sure to read this alert in full because every part of it is important!

3D Systems (DDD) has just surpassed its short-term key breakout point of $7.06 per share and is up by $0.34 or 5.02% today to $7.11 per share for a gain of 32.4% since NIA announced DDD as its latest brand new stock suggestion two weeks ago on October 6th at $5.37 per share.

Support.com (SPRT) hit a new 5-year high this morning of $2.45 per share for a gain of 39.2% since NIA announced SPRT as one of its latest Top 5 favorite overall stock suggestions three weeks ago on September 27th at $1.76 per share.

Copper is up by 0.60% today to $3.086 per lb and is getting ready to test its short-term key breakout point of $3.12 per lb. NIA's #1 favorite copper play Braveheart Resources (TSXV: BHT) is beginning to breakout from its most oversold levels in history. It bottomed two weeks ago at $0.065 per share where it had an insanely low 14-day relative strength index (RSI) of 14.84. BHT bounced by 30.77% last week to $0.085 per share and is up another 11.76% today to $0.095 per share. As you may recall we originally suggested BHT on June 29th at $0.055 per share and it rose to a high on August 20th of $0.17 per share for a gain of 209.09% from NIA's suggestion price. It is bullish that BHT did not return to our suggestion price of $0.055 per share and bottomed at a higher low. It also bullish that it is bouncing on low volume compared to the volume that it traded during its initial run from $0.055 up to $0.17.

We love Fiore Gold (TSXV: F) here at $1.56 per share. Within the next few trading days look for Fiore to announce record annual gold production for its fiscal year 2020, which ended on September 30, 2020. Fiore will likely hit new all-time highs of above $1.75 per share as soon as this week. On September 26th, all of Fiore's outstanding $1.70 and $1.77 per share warrants expired so the resistance that Fiore faced in early September where it was unable to close above $1.70 per share will now be gone for good. Fiore has consistently remained our #1 favorite producing gold miner ever since we announced it on November 22, 2018 at $0.23 per share as our #1 favorite overall stock suggestion for 2019. At Fiore's all-time high of $1.75 per share reached on September 10th it was up by 660.87% from our initial suggestion price. Fundamentally at $1.56 per share, Fiore Gold remains by far the #1 most undervalued producing gold miner. Fiore's current market cap is only USD$116.81 million and as of June 30th it had a net cash position of USD$14.265 million. Fiore's enterprise value is only USD$102.55 million. In fiscal 3Q 2020 alone, Fiore generated operating cash flow of USD$10.457 million. If we annualize Fiore's 3Q 2020 operating cash flow by multiplying it by 4 it equals USD$41.828 million. Fiore's enterprise value is only 2.45X its latest quarterly operating cash flow on an annualized basis! We are confident that Fiore will breakout above $2 per share before year-end and believe it could happen a lot sooner than anybody thinks is possible.

In the upcoming weeks, psilocybin mushrooms will receive major mainstream attention due to the November 3rd ballot initiatives in Oregon and Washington DC. In May 2019 the city of Denver, Colorado made history by becoming the first U.S. city to decriminalize psilocybin mushrooms. Oregon on November 3rd has an excellent chance of becoming the first state to pass an initiative allowing residents to legally purchase, possess, and consume psilocybin products, such as psilocybin-producing mushrooms to individuals aged 21 years or older.

NIA has so far only announced one psilocybin stock suggestion Numinus Wellness (TSXV: NUMI) and it is trading strongly today up by $0.025 or 7.46% to $0.36 per share! NUMI has already gained by 26.32% since NIA announced NUMI as one of its latest Top 5 favorite overall stock suggestions three weeks ago on September 27th at $0.285 per share!

In recent weeks after the successful IPO of Compass Pathways (CMPS) where the stock rapidly rose by 170.18% from its IPO price, we have been searching for a psilocybin biotech play with the best chance of becoming the next CMPS. NIA has discovered a small-cap company that it will soon be announcing as its #1 favorite psilocybin biotechnology stock suggestion!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from BHT of USD$30,000 cash for a six-month marketing contract. NIA has received compensation from NUMI of USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.